Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 2 boards, counting each seat separately. Longest: Charles River Laboratories International Inc., 3 years.
Regeneron Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 8, 2026 | Charles River Laboratories International Inc. | Grant or award | +1,438 | $177.62 | $255,418 |
| Jan 2, 2026 | Regeneron Pharmaceuticals Inc. | Grant or award | +155 | — | — |
| May 21, 2025 | Charles River Laboratories International Inc. | Grant or award | +946 | $134.98 | $127,691 |
| Jan 2, 2025 | Regeneron Pharmaceuticals Inc. | Grant or award | +166 | — | — |
| May 13, 2024 | Charles River Laboratories International Inc. | Grant or award | +559 | $228.41 | $127,681 |
| Jan 2, 2024 | Regeneron Pharmaceuticals Inc. | Grant or award | +135 | — | — |
| May 15, 2023 | Charles River Laboratories International Inc. | Grant or award | +664 | — | — |
| Jan 3, 2023 | Regeneron Pharmaceuticals Inc. | Grant or award | +40 | — | — |
| Jan 3, 2023 | Charles River Laboratories International Inc. | Grant or award | +244 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.